Sofinnova Ventures — 2020 Investments
1 investments dated 2020 · listed companies and verified rows first · show all
Aerovate Therapeutics, Inc.Aug 2020
Developing drugs for rare cardiopulmonary disease.
Boston, US
Board seatMaha KatabiJonathan Leff· per SEC Form D
Co-investorsAtlas Venture
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.